| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.144 | 618 | 2.274 | 63.435 | 61.926 | 161.371 | 44.950 | 283.329 | 340.685 | 500 |
| Total Income - EUR | 33.144 | 618 | 17.367 | 63.435 | 61.927 | 168.528 | 70.219 | 257.982 | 340.685 | 500 |
| Total Expenses - EUR | 8.345 | 942 | 16.183 | 14.567 | 26.250 | 31.742 | 68.234 | 131.609 | 148.630 | 30.054 |
| Gross Profit/Loss - EUR | 24.798 | -324 | 1.184 | 48.868 | 35.677 | 136.786 | 1.986 | 126.372 | 192.055 | -29.554 |
| Net Profit/Loss - EUR | 23.804 | -342 | 1.116 | 47.262 | 33.819 | 134.216 | 1.590 | 123.681 | 188.819 | -29.554 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Euro-Bio Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 31 | 0 | 0 | 0 | 0 | 7.157 | 9.190 | 9.218 | 10.341 | 9.734 |
| Current Assets | 25.972 | 2.384 | 13.590 | 67.146 | 55.278 | 130.544 | 137.312 | 206.496 | 235.936 | 93.301 |
| Inventories | 160 | 0 | 86 | 1.035 | 11.329 | 7.649 | 38.454 | 10.849 | 12.573 | 5.587 |
| Receivables | 15.321 | 0 | 13.423 | 41.806 | 28.146 | 90.238 | 64.104 | 174.928 | 111.124 | 86.475 |
| Cash | 10.491 | 2.384 | 82 | 24.304 | 15.803 | 32.657 | 34.754 | 20.719 | 112.239 | 1.239 |
| Shareholders Funds | 23.812 | 2.366 | 3.441 | 50.639 | 52.922 | 134.257 | 123.143 | 195.956 | 188.867 | -36.918 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.191 | 18 | 10.149 | 4.584 | 2.426 | 3.623 | 33.995 | 32.193 | 67.811 | 143.501 |
| Income in Advance | 0 | 0 | 0 | 11.922 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Euro-Bio Consulting Srl